Nelson Americo Hossne, Jr

Title: Nelson Americo Hossne, Jr: Innovator in Ischemic Tissue Cell Therapy

Introduction

Nelson Americo Hossne, Jr. is a notable inventor based in São Paulo, Brazil. He has made significant contributions to the field of medical therapies, particularly in the treatment of ischemic diseases. His innovative approach focuses on utilizing cell therapy to address critical health conditions.

Latest Patents

Hossne holds a patent for "Ischemic tissue cell therapy." This invention is directed towards compositions and methods for treating ischemic diseases and conditions, specifically targeting myocardial, CNS/brain, and limb ischemia. The patent outlines methods for treating disorders by administering monocytes obtained from various sources, including umbilical cord blood, peripheral blood, or bone marrow. The therapeutic efficacy is achieved by administering these cells at a strategically determined time point. One embodiment of the invention involves injecting the cells into ischemic myocardium to treat angina.

Career Highlights

Throughout his career, Hossne has worked with notable organizations, including Cryopraxis Criobiologia Ltda. and the Federal University of São Paulo (Universidade Federal De São Paulo—UNIFESP). His work in these institutions has allowed him to advance his research and contribute to the medical field significantly.

Collaborations

Hossne has collaborated with esteemed colleagues such as Paul R. Sanberg and Alison Elizabeth Willing. These partnerships have enriched his research and expanded the impact of his innovations in the medical community.

Conclusion

Nelson Americo Hossne, Jr. is a pioneering inventor whose work in ischemic tissue cell therapy has the potential to transform treatment options for patients suffering from ischemic diseases. His contributions to medical science highlight the importance of innovation in improving health outcomes.